InterCure Ltd. (INCR)

2.3600 -0.0200 (-0.84%) At close: 04:00PM EDT

InterCure Ltd.

85 Medinat ha-Yehudim Street
Herzliya 4676670
Israel
972 7 746 05012
https://www.intercure.co

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 370

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Alexander Rabinovich	CEO & Director	500k	N/A	1971
Mr. Amos Cohen	Chief Financial Officer	848k	N/A	1979
Einat Zehavi	Vice President of Sales	842k	N/A	N/A
Mr. Omri Batzir	Corporate Controller	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Corporate governance

InterCure Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.